Highlights • There is still uncertainty about PI-RADS 3 lesions. • Machine learning (ML) models are effective in biopsy decision making in PI-RADS 3 lesions. • Parameters such as SII,…
Highlights • GGT for patients with PCa increased from 21 in Q2 2015 to 1,509 in Q3 2020. • Proportion of GGT ordered by urologists increased from 0% in 2015…
Highlights • Our study explores the efficacy of prostate ablation, both whole-gland and partial-gland ablation, as an emerging treatment for localized prostate cancer, emphasizing its potential in reducing quality of…
Highlights • Significant correlation between HbA1c and prostate cancer mortality not incidence. • 26% and 21% increase in the risk of CSM and ACM for each 1% increase in HbA1c….
Highlights • Observational studies suggest favorable associations between statin use and prostate cancer (CaP) outcomes, data from randomized-controlled trials remain inconclusive. • We explored the relationship between statin use and…
Highlights • Among individuals undergoing targeted biopsy of PI-RADS 5 lesions on prostate MRI, 15.2% were found to have Gleason Grade Group 1 prostate cancer. • The majority of those…
Highlights • All of Us is a prospective clinic genomic database with a diverse population. • Black, Hispanic, and Asian men are less likely to be screened for prostate cancer….
Highlights • Renal Cell Carcinoma (RCC) as high number cases in western countries. • 3D reconstructions of kidneys and tumors are useful for the surgical operations. • Contact Surface Area…
Highlights • Regarding the controversy over the prognostic value of the primary tumor, our study supports that the level of IVCTT and tumor size have no significant prognostic value. •…
Highlights • Combination systemic therapies (STs) including immuno-oncologic (IO) and VEGF-inhibiting (VEGFi) agents, predominantly tyrosine kinase inhibitors (TKI), have become the standard of care for metastatic clear cell carcinoma. •…
